Restless Leg Syndrome Clinical Trials

[ksxroads]

I was unable to load the clinical trials page on the RLS website, so I thought I might post what I found at the US National Institutes of Health. For anyone who might be interested in participating, full information may be found at

http://clinicaltrials.gov/search/term=R ... 20Syndrome


If the above link does not work, the link to the clinical trials is found at the bottom of this webpage

http://www.ninds.nih.gov/disorders/rest ... s_legs.htm


1. Recruiting Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
Condition: Restless Legs Syndrome

2. Not yet recruiting Restless Legs Syndrome Exercise Intervention
Conditions: Restless Legs Syndrome; Insomnia; Daytime Sleepiness

3. Recruiting Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome Conditions: Sleep Disorder; Restless Legs Syndrome

4. Recruiting XP13512 Versus Placebo in Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome

5. Recruiting Swiss Restless Legs Syndrome Trial (SRLS)
Condition: Restless Legs Syndrome

6. Recruiting Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)
Condition: Restless Legs Syndrome

7. Recruiting Ropinirole Immediate Release Tablets In Young Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome

8. Recruiting A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
Condition: Idiopthic Restless Legs Syndrome

9. Recruiting Sleep Disorders Management, Health and Safety in Police
Conditions: Sleep Disorders; Sleep Apnea, Obstructive; Restless Legs Syndrome; Sleep Disorders, Circadian Rhythm; Sleep Initiation and Maintenance Disorders

10. Not yet recruiting Comprehensive Police Fatigue Management Program
Conditions: Sleep Disorders; Sleep Apnea, Obstructive; Restless Legs Syndrome; Sleep Disorders, Circadian Rhythm; Sleep Initiation and Maintenance Disorders

11. Recruiting Double-Blind, Randomized, Placebo- and Positive-Controlled, Parallel-Group Trial to Assess the Potential Electrocardiographic Effects of Rotigotine Transdermal System Up to 120cm2/54.0mg/Day in Subjects With Advanced-Stage Idiopathic Parkinson’s Disease: a “Thorough” QT/QTc Trial
Conditions: Advanced-Stage Idiopathic Parkinson’s Disease